2026年7月3日
學院在研究資助局「優配研究金」2026/27 競逐中再創佳績,成功囊括八項研究撥款。獲資助項目數量連續兩年穩步攀升,充分彰顯學院在中醫藥科研領域的卓越實力與領先地位。
本年度獲資助的項目聚焦中醫藥、生物醫學和創新藥物研發等前沿領域,並貫徹跨學科研究的理念。相關研究深具轉化潛力,有望拓展嶄新治療策略,闡明創新藥物與療法的機制,推動整合醫學與疾病管理模式的發展。
院長李敏教授對學院科研人員的驕人成績深感自豪,她表示:「學院近年在校外競爭性資助中屢獲佳績,新晉研究人員表現尤其矚目,充分體現了學院的科研實力和人才培育成果廣獲學界肯定。」
展望未來,學院將繼續立足科研創新前沿,致力融合傳統中醫藥智慧與現代科學技術,為增進人類健康謀福祉作出更大貢獻。
由學院領導的2026/27優配研究金資助項目(只提供英文版)
Principal Investigator | Project Title |
Professor Li Min 李敏教授 | Investigating the Specific Roles of TFE3 in CAPON-Mediated Tauopathy in Alzheimer's disease and Therapeutic Potential of Corynoxine |
Professor Zhang Ge 張戈教授 | Sclerostin-loop3-LRP4 interaction in adipocytes could be required by sclerostin to impair whole-body lipid/glucose metabolism |
Professor Han Quanbin Simon 韓全斌教授 | Investigating the Structure-Activity Relationships and Binding Interactions between polysaccharides and GP2/TLR4 receptors: Implications for Intestinal Lymphatic Absorption and Immune Modulation |
Professor Cheung King-ho 張敬浩教授 | Deciphering Genistein’s Neuroprotective |
Professor Li Fangfei 李芳菲教授 | Targeted Degradation of Nuclear uPA to Inhibit Perineural Invasion in Pancreatic Cancer via PROTAC Strategy |
Dr. Li Lifeng Cherry 李利鋒博士 | From a traditional pediatric remedy Goat Bezoar to functional food: Urolithins as a novel intervention for pediatric respiratory health |
Dr. Chen Qilei 陳綺蕾博士 | Investigating a novel synovial crosstalk: Fibroblast-like synoviocyte exosomal miRNAs drive pathogenic macrophage reprogramming in rheumatoid arthritis |
Dr. Cheung Chat-pan Kenneth 張質彬博士 | Investigating Hyodeoxycholic Acid as a Regulator of Immunometabolism in Rheumatoid Arthritis |